{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:40:18Z","timestamp":1787319618408,"version":"build-2736575974"},"reference-count":26,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.ejso.2023.06.023","type":"journal-article","created":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T20:56:52Z","timestamp":1687813012000},"page":"106971","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Pathological determinants of outcome following resection of locally advanced or locally recurrent rectal cancer"],"prefix":"10.1016","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8014-3762","authenticated-orcid":false,"given":"Laura E.","family":"Gould","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward T.","family":"Pring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan","family":"Moorghen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0070-6332","authenticated-orcid":false,"given":"Elaine M.","family":"Burns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Antoniou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin W.","family":"Steele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Campbell SD.","family":"Roxburgh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8723-9409","authenticated-orcid":false,"given":"John T.","family":"Jenkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejso.2023.06.023_bib1","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1002\/cncr.29993","article-title":"Changes in treatment patterns for patients with locally advanced rectal cancer in the United States over the past decade: an analysis from the National Cancer Data Base","volume":"122","author":"Sineshaw","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2023.06.023_bib2","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1002\/bjs.9192","article-title":"Consensus statement on the multidisciplinary management of patients with recurrent and primary rectal cancer beyond total mesorectal excision planes","volume":"100","author":"Collaborative","year":"2013","journal-title":"Br J Surg"},{"key":"10.1016\/j.ejso.2023.06.023_bib3","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1056\/NEJMoa060829","article-title":"Chemotherapy with preoperative radiotherapy in rectal cancer","volume":"355","author":"Bosset","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ejso.2023.06.023_bib4","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1200\/JCO.2010.33.1595","article-title":"Nomograms for predicting local recurrence, distant metastases, and overall survival for patients with locally advanced rectal cancer on the basis of european randomized clinical trials","volume":"29","author":"Valentini","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2023.06.023_bib5","doi-asserted-by":"crossref","first-page":"4620","DOI":"10.1200\/JCO.2006.06.7629","article-title":"Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203","volume":"24","author":"G\u00e9rard","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2023.06.023_bib6","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1055\/s-2007-984870","article-title":"Management of locally advanced primary and recurrent rectal cancer","volume":"20","author":"de Wilt","year":"2007","journal-title":"Clin Colon Rectal Surg"},{"key":"10.1016\/j.ejso.2023.06.023_bib7","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1002\/bjs.6699","article-title":"Locally recurrent rectal cancer in Norway","volume":"96","author":"Hansen","year":"2009","journal-title":"Br J Surg"},{"key":"10.1016\/j.ejso.2023.06.023_bib8","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1097\/01.SLA.0000059972.90598.5F","article-title":"Curative potential of multimodality therapy for locally recurrent rectal cancer","volume":"237","author":"Hahnloser","year":"2003","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2023.06.023_bib9","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1245\/s10434-006-9256-9","article-title":"A\u00a0population-based study on the management and outcome in patients with locally recurrent rectal cancer","volume":"14","author":"Palmer","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2023.06.023_bib10","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/SLA.0000000000001524","article-title":"The outcomes and patterns of treatment failure after surgery for locally recurrent rectal cancer","volume":"264","author":"Harris","year":"2016","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2023.06.023_bib11","doi-asserted-by":"crossref","DOI":"10.1093\/annonc\/mdx224","article-title":"Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"28","author":"Glynne-Jones","year":"2017","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejso.2023.06.023_bib12","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/SLA.0000000000002528","article-title":"Surgical and survival outcomes following pelvic exenteration for locally advanced primary rectal cancer: results from an international collaboration","volume":"269","year":"2019","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2023.06.023_bib13","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/bjs.10734","article-title":"Factors affecting outcomes following pelvic exenteration for locally recurrent rectal cancer","volume":"105","year":"2018","journal-title":"Br J Surg"},{"key":"10.1016\/j.ejso.2023.06.023_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijsu.2022.106738","article-title":"A\u00a0systematic review of the pathological determinants of outcome following resection by pelvic exenteration of locally advanced and locally recurrent rectal cancer","volume":"104","author":"Gould","year":"2022","journal-title":"Int J Surg"},{"key":"10.1016\/j.ejso.2023.06.023_bib15","author":"Wilkins"},{"key":"10.1016\/j.ejso.2023.06.023_bib30","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1007\/s10151-014-1234-9","article-title":"Extended lateral pelvic sidewall excision (ELSiE): an approach to optimize complete resection rates in locally advanced or recurrent anorectal cancer involving the pelvic sidewall","volume":"18","author":"Shaikh","year":"2014","journal-title":"Tech Coloproctol"},{"key":"10.1016\/j.ejso.2023.06.023_bib31","doi-asserted-by":"crossref","DOI":"10.1111\/codi.13226","article-title":"High subcortical sacrectomy: a novel approach to facilitate complete resection of locally advanced and recurrent rectal cancer with high (S1-S2) sacral extension","volume":"18","author":"Shaikh","year":"2016","journal-title":"Colorectal Dis"},{"key":"10.1016\/j.ejso.2023.06.023_bib17","series-title":"Minimally invasive versus open pelvic exenterations for rectal cancer: a comparative analysis of perioperative and 3-year oncological outcomes","author":"Kazi","year":"2021"},{"key":"10.1016\/j.ejso.2023.06.023_bib18","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s00384-015-2353-0","article-title":"Layer-oriented total pelvic exenteration for locally advanced primary colorectal cancer","volume":"31","author":"Koda","year":"2016","journal-title":"Int J Colorectal Dis"},{"key":"10.1016\/j.ejso.2023.06.023_bib22","doi-asserted-by":"crossref","first-page":"20","DOI":"10.4274\/tjcd.galenos.2020.2020-8-1","article-title":"Pelvic exenteration for recurrent rectal cancer: a single institution experience","volume":"31","author":"Culcu","year":"2021","journal-title":"Turkey J Colorect Dis"},{"key":"10.1016\/j.ejso.2023.06.023_bib23","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.amjsurg.2014.01.008","article-title":"Pelvic exenterations for specific extraluminal recurrences in the era of total mesorectal excision: is there still a chance for cure?: a single-center review of patients with extraluminal pelvic recurrence for rectal cancer from March 2004 to November 201","volume":"209","author":"Ghouti","year":"2015","journal-title":"Am J Surg"},{"key":"10.1016\/j.ejso.2023.06.023_bib24","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1097\/PAS.0b013e3181d296ef","article-title":"Objective criteria for the grading of venous invasion in colorectal cancer","volume":"34","author":"Sato","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ejso.2023.06.023_bib25","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1093\/annonc\/mdt593","article-title":"The relationship between tumour stroma percentage, the tumour microenvironment and survival in patients with primary operable colorectal cancer","volume":"25","author":"Park","year":"2014","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejso.2023.06.023_bib26","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1016\/S0140-6736(18)30789-X","article-title":"International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study","volume":"391","author":"Pag\u00e8s","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.ejso.2023.06.023_bib27","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1038\/nm.3967","article-title":"The consensus molecular subtypes of colorectal cancer","volume":"21","author":"Guinney","year":"2015","journal-title":"Nat Med"},{"key":"10.1016\/j.ejso.2023.06.023_bib28","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1186\/1471-2407-12-260","article-title":"Colon cancer molecular subtypes identified by expression profiling and associated to stroma, mucinous type and different clinical behavior","volume":"12","author":"Perez-Villamil","year":"2012","journal-title":"BMC Cancer"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798323005644?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798323005644?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:52:13Z","timestamp":1760061133000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798323005644"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":26,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S0748798323005644"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2023.06.023","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pathological determinants of outcome following resection of locally advanced or locally recurrent rectal cancer","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2023.06.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106971"}}